GLMD Stock Soars: Galmed Pharmaceuticals Makes Waves in Biotech Market
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), a clinical-stage biopharmaceutical company focused on liver disease treatments, has captured the attention of investors with its remarkable stock performance over the past 24 hours. The company, headquartered in...